Putting the Genetic Information Nondiscrimination Act in context.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Toward a framework for measuring the impact of ELSI research.Nature genetics · 2026
   Article
2. Big Data in Oncology Nursing Research: State of the Science.Seminars in oncology nursing · 2023
   Review
3. Functional genomics data: privacy risk assessment and technological mitigation.Nature reviews. Genetics · 2022
   Review
4. Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
   Article
5. Health Policy and Privacy Challenges Associated With Digital Technology.JAMA network open · 2020
   Article
6. Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries.Nature medicine · 2019
   Review
7. Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?Genetic testing and molecular biomarkers · 2016
   Article
8. Privacy Risks from Genomic Data-Sharing Beacons.American journal of human genetics · 2015
   Article
9. Communicating results in post-Belmont era biomonitoring studies: lessons from genetics and neuroimaging research.Environmental research · 2015
   Review
10. The fiduciary relationship model for managing clinical genomic "incidental" findings.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2014
    Article
11. Ethical, legal, and social implications of incorporating genomic information into electronic health records.Genetics in medicine : official journal of the American College of Medical Genetics · 2013
    Review
12. Point-counterpoint. Patient autonomy and incidental findings in clinical genomics.Science (New York, N.Y.) · 2013
    Article
13. Evolving perspectives on genetic discrimination in health insurance among health care providers.Familial cancer · 2010
    Article
14. Keeping the GINA in the bottle: assessing the current need for genetic non-discrimination legislation in Canada.Open medicine : a peer-reviewed, independent, open-access journal · 2010
    Article
15. The ghost in our genes: legal and ethical implications of epigenetics.Health matrix (Cleveland, Ohio : 1991) · 2009
    Article
16. Currents in contemporary ethics. GINA, the ADA, and genetic discrimination in employment.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2008
    Article

Corrections and comments

• Comment on
  Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians.2008

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as